These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11709874)

  • 1. Insulin resistance: implications for Maori.
    Joseph N
    Pac Health Dialog; 2000 Mar; 7(1):122-3. PubMed ID: 11709874
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin resistance in a rural Maori community.
    Tipene-Leach D; Pahau H; Joseph N; Coppell K; McAuley K; Booker C; Williams S; Mann J
    N Z Med J; 2004 Dec; 117(1207):U1208. PubMed ID: 15608803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Childhood obesity increases the risk of coronary artery disease].
    Nuutinen O; Nuutinen M
    Duodecim; 2001; 117(13):1356-62. PubMed ID: 12184126
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing diabetes--time is running out.
    Scragg R
    N Z Med J; 2004 Dec; 117(1207):U1220. PubMed ID: 15608813
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the metabolic syndrome: the new epidemic.
    Sorrentino MJ
    Am J Cardiol; 2005 Aug; 96(4A):3E-7E. PubMed ID: 16098835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance syndrome.
    Cheng TO
    South Med J; 1998 Jul; 91(7):697. PubMed ID: 9671849
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular risk factors in the Lublin Region population with and without type-2 diabetes mellitus.
    Mardarowicz G; Lopatyński J; Szcześniak G
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):471-7. PubMed ID: 15323239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolic syndrome].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1991 Jul; 85(14):651-6. PubMed ID: 1926931
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin sensitivity and intramyocellular lipid concentrations in young Maori men.
    Stannard SR; Holdaway MA; Sachinwalla T; Cunningham CW
    Diabet Med; 2007 Nov; 24(11):1205-12. PubMed ID: 17593244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
    Collins FM
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S460-71. PubMed ID: 12408409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypertriglyceridaemic waist in New Zealand Maori.
    Bell D; McAuley KA; Mann J; Murphy E; Williams S
    Asia Pac J Clin Nutr; 2004; 13(1):74-7. PubMed ID: 15003918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the controversies of insulin therapy in patients with type 2 diabetes mellitus.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S3-6. PubMed ID: 16021782
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabesity: the deadly pentad disease.
    Daly A
    Diabetes Educ; 1994; 20(2):156-8, 160-2. PubMed ID: 7851230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sibutramine in treatment of obesity. Therapeutic premises in patients with essential hypertension, diabetes, hyperlipidemia].
    Rajzer M; Wojciechowska W; Kawecka-Jaszcz K
    Przegl Lek; 2004; 61(2):94-8. PubMed ID: 15230149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
    Bari MR; Ostgren CJ; Råstam L; Lindblad U
    Scand J Prim Health Care; 2006 Dec; 24(4):211-7. PubMed ID: 17118860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.